Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S. Gen Dent. 2010 Nov-Dec; 58(6):484-92; quiz 493-4.